These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 34298417)

  • 1. Corrigendum to "Activation of angiotensin II type 2 receptor attenuates lung injury of collagen-induced arthritis by alleviating endothelial cell injury and promoting Ly6C
    Xu Q; Chen J; Ye W; Zhang C; Wang D; Wei W; Hu S
    Eur J Pharmacol; 2023 Sep; 954():175907. PubMed ID: 37460388
    [No Abstract]   [Full Text] [Related]  

  • 2. Corrigendum to "Cannabinoid receptors are involved in the protective effect of a novel curcumin derivative C66 against CCl4-induced liver fibrosis" [Eur. J. Pharmacol. 779 (2016) 20-30 doi: 10.1016/j.ejphar.2016.02.067].
    Huang SS; Chen DZ; Wu H; Chen RC; Du SJ; Dong JJ; Liang G; Xu LM; Wang XD; Yang YP; Yu ZP; Feng WK; Chen YP
    Eur J Pharmacol; 2024 Aug; 977():176713. PubMed ID: 38849042
    [No Abstract]   [Full Text] [Related]  

  • 3. Corrigendum to "N-arachidonoylphenolamine alleviates ischaemia/reperfusion-induced cardiomyocyte necroptosis by restoring proteasomal activity" [Eur. J. Pharmacol. (2024) 963 176235].
    Bai JQ; Li PB; Li CM; Li HH
    Eur J Pharmacol; 2024 Feb; 965():176316. PubMed ID: 38216371
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "SUMO2-mediated SUMOylation of SH3GLB1 promotes ionizing radiation-induced hypertrophic cardiomyopathy through mitophagy activation"[Eur. J. Pharmacol. 924 (2022) 174980].
    Gao A; Zou J; Mao Z; Zhou H; Zeng G
    Eur J Pharmacol; 2024 Apr; 968():176456. PubMed ID: 38395694
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "The prophylaxis and treatment potential of supplements for COVID-19" [Eur. J. Pharmacol. 887 (15 November 2020) 173530].
    Sahebnasagh A; Saghafi F; Avan R; Khoshi A; Khataminia M; Safdari M; Habtemariam S; Ghaleno HR; Nabavi SM
    Eur J Pharmacol; 2024 Jun; 972():176571. PubMed ID: 38614058
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Guggulsterone inhibits migration and invasion through proteasomal and lysosomal degradation in human glioblastoma cells" [Eur. J. Pharmacol. 938 (2023) 175411].
    Yang JF; Chang HH; Chen TM; Tsai WC; Huang WY; Lo CH; Lin CS; Shen PC; Chen Y
    Eur J Pharmacol; 2023 Dec; 960():176183. PubMed ID: 37953156
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Na(+)-dependent inactivation of vascular Na(+)/Ca(2+) exchanger responsible for reduced peripheral blood flow in neuropathic pain model" [Eur. J. Pharmacol. 910 (2021) 174448].
    Ishida H; Yamaguchi M; Saito SY; Furukawa T; Shannonhouse JL; Kim YS; Ishikawa T
    Eur J Pharmacol; 2024 May; 970():176495. PubMed ID: 38490839
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Discovery of anticancer agents with c-Met inhibitory potential by virtual and experimental screening of a chemical library" [Europ. J. Pharmacol. (2023) 938: 175395].
    Mortazavi M; Raufi E; Damghani T; Khoshneviszadeh M; Edraki N; Eskandari M; Giovannetti E; Peters GJ; Pirhadi S; Firuzi O
    Eur J Pharmacol; 2024 Sep; 978():176777. PubMed ID: 38954904
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of the analgesic effect of dezocine and esketamine in combination with sufentanil respectively after laparoscopic cholecystectomy: a prospective randomized controlled study.
    Deng B; Wang D; Xie Z; Wang Y; Huang L; Jiang M; Shen T
    BMC Anesthesiol; 2024 Feb; 24(1):51. PubMed ID: 38317099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CaMKII Phosphorylation in Primary Somatosensory Cortical Neurons is Involved in the Inhibition of Remifentanil-induced Hyperalgesia by Lidocaine in Male Sprague-Dawley Rats.
    Cui W; Wang S; Han R; Wang Q; Li J
    J Neurosurg Anesthesiol; 2016 Jan; 28(1):44-50. PubMed ID: 25811361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-acetyl-cysteine attenuates remifentanil-induced postoperative hyperalgesia via inhibiting matrix metalloproteinase-9 in dorsal root ganglia.
    Liu Y; Ni Y; Zhang W; Sun YE; Ma Z; Gu X
    Oncotarget; 2017 Mar; 8(10):16988-17001. PubMed ID: 28199982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corrigendum to 'Dezocine attenuates the remifentanil-induced postoperative hyperalgesia by inhibition of phosphorylation of CaMKⅡα' [Eur J Pharmacol. 2020 Feb 15; 869: 172882].
    Zhou J; Qi F; Hu Z; Zhang L; Li Z; Wang ZJ; Tang H; Chen Z
    Eur J Pharmacol; 2021 Oct; 908():174359. PubMed ID: 34298417
    [No Abstract]   [Full Text] [Related]  

  • 13. Dezocine attenuates the remifentanil-induced postoperative hyperalgesia by inhibition of phosphorylation of CaMKⅡα.
    Zhou J; Qi F; Hu Z; Zhang L; Li Z; Wang ZJ; Tang H; Chen Z
    Eur J Pharmacol; 2020 Feb; 869():172882. PubMed ID: 31863769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrathecal injection of KN93 attenuates paradoxical remifentanil-induced postoperative hyperalgesia by inhibiting spinal CaMKII phosphorylation in rats.
    Jiang M; Zhang W; Cheng C; Ma Z; Gu X
    Pharmacol Biochem Behav; 2015 Jul; 134():35-41. PubMed ID: 25937575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrathecal administration of roscovitine prevents remifentanil-induced postoperative hyperalgesia and decreases the phosphorylation of N-methyl-D-aspartate receptor and metabotropic glutamate receptor 5 in spinal cord.
    Liu X; Liu Y; Zhang J; Zhang W; Sun YE; Gu X; Ma Z
    Brain Res Bull; 2014 Jul; 106():9-16. PubMed ID: 24769228
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.